Related Experiment Videos
Computed tomography in invasive pulmonary aspergillosis.
1Istituto di Radiologia, University of Rome La Sapienza, Rome, Italy.
Acta Radiologica (Stockholm, Sweden : 1987)
|November 1, 1989
Summary
Early chest computed tomography (CT) can identify invasive pulmonary aspergillosis in leukemia patients. This imaging technique reveals characteristic nodules with a halo sign, aiding in the early diagnosis of fungal pneumonia.
Area of Science:
- Radiology
- Infectious Diseases
- Oncology
Background:
- Invasive pulmonary aspergillosis (IPA) and similar angiotrophic fungal pneumonias pose a significant threat to immunocompromised hosts.
- Early diagnosis of IPA is crucial for improving survival rates in patients with hematological malignancies.
Purpose of the Study:
- To evaluate the utility of early chest computed tomography (CT) in the recognition of invasive pulmonary aspergillosis and other fungal pneumonias.
- To identify characteristic CT findings associated with early-stage fungal pneumonia in neutropenic leukemia patients.
Main Methods:
- Chest CT scans were performed on 11 leukemia patients with chemotherapy-induced neutropenia during fungal pneumonia.
- Scans included both contrast-enhanced (n=8) and non-contrast (n=5) examinations.
- CT findings were analyzed based on the timing of the examination relative to the clinical onset of pneumonia.
Main Results:
- Early CT scans (before day 7) consistently showed one or more nodules or mass-like infiltrates with a surrounding halo of low attenuation in all 5 patients.
- This "halo sign" was absent in later CT examinations (after 7 and 15 days).
- Contrast-enhanced CT revealed peripheral enhancement in 4/8 cases, presenting a "target" feature.
Conclusions:
- Early chest CT is a valuable tool for the early recognition of invasive pulmonary aspergillosis and opportunistic fungal pneumonias.
- The presence of nodules with a halo sign on early CT is a key indicator of fungal pneumonia in neutropenic patients.
- Incorporating early chest CT into the management of opportunistic pneumonias can potentially improve patient outcomes.